EXAM 2 PQ Flashcards
Neuromuscular, nondepolarizing blockers which exhibit longer durations of action (greater than about half an hour) are most likely eliminated by:
Renal
Which one(s) of the following “intermediate-acting” steroid neuromuscular blocking drugs Exhibit elimination as a result of hepatic metabolism or biliary excretion.
Vecuronium and Rocuronium
Intermediate acting steroid NMB drugs
Vecuronium and Rocuronium
This agent is most likely to ensure maintenance of the cardiovascular reflex, a condition preferable during anesthesia
Vecuronium
Cleared most slowly by the liver:
Pancuronium
Characteristic(s) of nondepolarizing neuromuscular blocking drugs:
Lipid soluble
This intermediate-acting isoquinoline-type intermediate acting nondepolarizing drug exhibits Hofman elimination (spontaneous breakdown).
Atracurium
T/FNeuromuscular blockade associated with nondepolarizing drugs is highly correlated with the elimination half-life.
True
Quaternary, charged, neuromuscular blocking drugs) show essentially NO Central effects after typical clinical doses.
True
Pharmacokinetic properties/properties of nondepolarizing neuromuscular blocking drugs:
Volume of distribution comparable to the blood volume
This neuromuscular blocking agent exhibits a sufficient anti-vagal action such that tachycardia may ensue.
PANCURONIUM
Compared to atricurium, cisatracurium is:
NOT dependent on the liver for inactivation.
NOT likely to cause histamine release.
T/F Neuromuscular blockade due to depolarization induced by agents such as succinylcholine is initially described as a phase I block.
True
Muscle cell changes associated with prolonged depolarization include:
Reduced Potassium
Over time and with increasing succinylcholine concentrations, neuromuscular blockade may transition from a.
depolarizing, phase I block to a non-depolarizing phase II block
Neuromuscular blockade reversal agent.
Sugammadex
Phase I blockade could be potentiated by which one(s) of the following?
Edrophonium
Donepezil
The prototypical depolarizing-type neuromuscular blocking drug:
Succinylcholine
Succinylcholine, an example of a depolarizing neuromuscular blocker, exhibits longer duration compared to acetylcholine mainly due to which one(s) of the following?
Resistance to inactivation by acetylcholinesterase
_______is more clinically advantageous compared atracurium and as a result has replaced atracurium in practice.
Cisatracurium
Botulinum toxin which may be used to manage ocular blepharospasm as well as control other muscle spasms block neuromuscular transmission mainly through
inhibition of acetylcholine release.
Isoquinoline derivative:
atracurium
Vlinical condition associated with spasticity:
Stroke, MS
Spasticity Characteristics
muscle weakness
increased flexor muscle spasm
increase in tonic stretch reflexes
Sequence of events following IV neuromuscular-blocking injection (nondepolarizing drug) to an awake patient:{first presentations to last}
difficulty in focusing, mandibular muscle weakness, ptosis, diplopia, dysphagia
Nondepolarizing neuromuscular agents – elimination characteristics
renal elimination: long half lives – longer ration of action > 35 minutes; hepatic elimination: shorter half lives, less than 30 minutes
Isoquinoline derivative:
-Acurium
Liver failure will have the most significant effect on the duration of action of which NDNMB
Rocuronium
Drugs that does not decrease butyrylcholinesterase activity?
Ranitidine
This drug class causes resistance to NMB drugs
Anticonvulsants (carbamezipine , phenytoin)
Elevated Laudanosine associated with
ATRACURIUM
NDNMB with the most potent active metabolite
VECURONIUM
No active metabolite with this benzylisoquinoliniu
CIsatracurium
What is the metabolite of vecuronium
3-OH, 80% as potent
During surgery , an adult patient is given a 2nd dose of succinylcholine approx 5 minutes after the first dose, the scenario increase the chance of this side effect
BRADYCARDIA
AVOID This NDNMB is asthmatic patients
ATRACURIUM